Never-before-seen electron behavior could help scientists create superwires for supercharged technology.

With Omicron landing in the U.S. this week, Harvard epidemiologist William Hanage reviewed what we know and the many things still unknown about the fast-moving coronavirus variant.

In a comparison study, the Moderna vaccine was slightly more effective than the Pfizer vaccine in preventing COVID-19 infection, hospitalization, and death.

Breakthrough COVID-19 cases in vaccinated people may be less likely to spread infection because virus is shed for a shorter period of time as opposed to infections in unvaccinated people.

Jonathan McDowell of the Harvard-Smithsonian Center for Astrophysics explains the science and objectives guiding the agency’s Double Asteroid Redirection Test.

Simar Singh Bajaj ’24 has had papers published in prestigious journals such as The New England Journal of Medicine and The Lancet.

Sarah Wakeman says that CDC report highlights need for U.S. to radically rethink response to opioid epidemic.

Mary Bushman, a research fellow in the Department of Epidemiology at Harvard Chan School, co-authored a recent paper that modeled variant threats.

A Harvard expert shares insight on the science and history of vaccine boosters and why we need them, speculating on a future that includes periodic COVID boosters.

Study says that physical activity later in life shifts energy away from processes that compromise health and toward mechanisms in the body that extend it.